Ironwood Pharmaceuticals (IRWD) will announce its Q1 earnings on May 7th, with a consensus EPS estimate of $0.24 and revenue estimate of $92.1M. Historically, IRWD has beaten EPS estimates 13% of the time and revenue estimates 50% of the time over the past two years.